MacuLogix Inc. announced its next generation of dark adaptation functional testing with AdaptDx Pro guided by Theia to detect age-related macular degeneration.
The company’s original AdaptDx was introduced in 2014 and has since been used by more than 1,000 eye care professionals to identify and properly monitor AMD. The new AdaptDx Pro includes a custom-designed headset for patient comfort and requires no dark room or external computer, according to a company press release.
“What makes the AdaptDx Pro so special is that it combines high-tech innovation and high-touch patient care without sacrificing functionality or results,” William McPhee, Maculogix president and CEO, said in the release. “AdaptDx Pro makes it simple to fit dark adaptation testing into any practice workflow.”
“The AdaptDx Pro is powered by Theia, a friendly on-board technician who guides patients through the test. She provides gentle reassurance with patient-driven instructions,” Julie Rodman, OD, Primary Care Optometry News Editorial Board, said in an interview with PCON. “This, in turn, frees up our technicians, allowing them to complete other tasks while the test is being performed.”
MacuLogix is providing AdaptDx table-top device owners with the first opportunity to upgrade to the AdaptDx Pro.
“This innovative technology is a true game changer in the diagnosis of macular degeneration,” Rodman added. – by Erin T. Welsh
Disclosure: Rodman reports she is a consultant for MacuLogix and Optovue.
Editor's note: This article was updated with a clarification from MacuLogix.